Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Empagliflozin on Functional and Structural Arterial Wall Characteristics

NCT03639545 is registered in ClinicalTrials.gov with University Medical Centre Ljubljana as lead sponsor.

NCT NCT03639545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03639545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Empagliflozin on Functional and Structural Arterial Wall Characteristics
Lead sponsor
University Medical Centre Ljubljana
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2018
Completion date
January 30, 2019
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes complications, diabetes mellitus, type 1, hypoglycemic agents, vascular stiffness